Campbell & CO Investment Adviser LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 401 filers reported holding REPLIGEN CORP in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
Campbell & CO Investment Adviser LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2022$441,000
+118.3%
2,359
+89.3%
0.10%
+85.2%
Q2 2022$202,000
-77.2%
1,246
-62.8%
0.05%
-82.2%
Q4 2021$887,000
+174.6%
3,350
-20.5%
0.30%
+149.2%
Q3 2019$323,000
+19.6%
4,213
-69.1%
0.12%
-26.5%
Q4 2014$270,00013,6490.17%
Other shareholders
REPLIGEN CORP shareholders Q2 2022
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders